Nu Skin Enterprises, Inc. (NUS) Given Consensus Rating of “Hold” by Analysts

Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have been assigned a consensus rating of “Hold” from the eleven analysts that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $65.38.

A number of equities analysts have recently commented on the company. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research downgraded Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Wednesday, December 20th. Finally, Citigroup restated a “buy” rating and issued a $81.00 price objective (up from $70.00) on shares of Nu Skin Enterprises in a report on Tuesday, January 23rd.

In related news, Chairman Steven Lund sold 108,132 shares of the firm’s stock in a transaction dated Friday, December 22nd. The stock was sold at an average price of $68.81, for a total transaction of $7,440,562.92. Following the sale, the chairman now directly owns 4,769 shares in the company, valued at approximately $328,154.89. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Over the last quarter, insiders have sold 195,978 shares of company stock worth $13,512,733. Company insiders own 5.20% of the company’s stock.

Several large investors have recently made changes to their positions in the stock. BlackRock Inc. raised its holdings in shares of Nu Skin Enterprises by 0.8% during the 4th quarter. BlackRock Inc. now owns 6,811,769 shares of the company’s stock valued at $464,767,000 after buying an additional 55,966 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Nu Skin Enterprises by 5.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,416,305 shares of the company’s stock valued at $87,443,000 after buying an additional 66,986 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Nu Skin Enterprises by 5.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,125,625 shares of the company’s stock valued at $69,204,000 after buying an additional 57,750 shares during the period. Old Mutual Global Investors UK Ltd. raised its holdings in shares of Nu Skin Enterprises by 63.1% during the 4th quarter. Old Mutual Global Investors UK Ltd. now owns 821,316 shares of the company’s stock valued at $56,038,000 after buying an additional 317,869 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in Nu Skin Enterprises by 1.1% during the 4th quarter. Bank of New York Mellon Corp now owns 754,996 shares of the company’s stock valued at $51,514,000 after purchasing an additional 8,462 shares in the last quarter. Institutional investors and hedge funds own 78.00% of the company’s stock.

Nu Skin Enterprises (NYSE NUS) traded up $0.94 during trading on Friday, hitting $67.60. The stock had a trading volume of 444,686 shares, compared to its average volume of 326,632. The stock has a market cap of $3,509.65, a P/E ratio of 24.76, a price-to-earnings-growth ratio of 2.07 and a beta of 1.46. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a 52 week low of $47.10 and a 52 week high of $74.45.

WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/10/nu-skin-enterprises-inc-nus-given-consensus-rating-of-hold-by-analysts.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply